Clinical Trial ‘Stockpile’ Would Boost Crisis Response: Woodcock

Jan. 26, 2021, 9:08 PM

A new clinical trials network built into community practices, where most patients receive their health care, would better prepare the nation for the next pandemic, acting FDA Commissioner Janet Woodcock said.

“We need a national clinical trials capacity stockpile, just as we need a stockpile of medicines and equipment. And the stockpile cannot sit idle waiting for a pandemic to occur,” Woodcock said Tuesday at a National Academies workshop.

If that proposal were to become a reality, it would mark a big change as academic medical centers have long served as the major hub for clinical trials. Many of those ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.